Sifting through countless of stocks in the Health Care Equipment & Supplies industry can be tedious, and sometimes two stocks are just too similar to judge which is the better investment. If you’re on the fence about investing in Integra LifeSciences Holdings Corporation or Stevanato Group S.p.A. because you’re not sure how they measure up, it’s important to compare them on a few factors before making your decision.

Read on to learn how Integra LifeSciences Holdings Corporation and Stevanato Group S.p.A. compare based on key financial metrics to determine which better meets your investment needs.

About Integra LifeSciences Holdings Corporation and Stevanato Group S.p.A.

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates through Codman Specialty Surgical and Tissue Technologies segments. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment. It also offers after-market services; surgical headlamps and instrumentation; instrument patterns and surgical and lighting products to hospitals, surgery centers, dental, podiatry, and veterinary offices. In addition, the company provides treatment of acute wounds, such as burns; chronic wounds, including diabetic foot ulcers; and surgical tissue repair applications, including hernia reinforcement, tendon protection, and peripheral nerve repair. Further, it offers skin and wound repair, plastics and surgical reconstruction products, and nerve and tendon repair products. Additionally, the company is involved in the ear, nose, and throat business that includes instrumentation, balloon technologies for sinus dilation and eustachian tube dilation, and surgical navigation systems. It offers its products directly through various salesforces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, the Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was formerly known as Integra LifeSciences Corp. and changed its name to Integra LifeSciences Holdings Corporation in June 1995. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide solutions for biopharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. It operates through two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. The company offers drug containment solutions comprising pre-fillable syringes, cartridges, vials, and ampoules; in-vitro diagnostic solutions; drug delivery systems, including pen injectors, auto-injectors, and wearable injectors; diagnostic laboratory consumables; analytical and regulatory support services; medical devices; pharmaceutical visual inspection machines; assembling and packaging machines; glass converting machines; and after-sales services, such as line optimization and line conversions, training, logistics, spare parts and maintenance services. It also provides contract development and manufacturing services for customer-owned drug delivery devices. The company serves pharmaceutical, biotechnology, diagnostics, and life sciences companies; and drug products, glass packaging, and fill and finish contract manufacturers. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. is a subsidiary of Stevanato Holding S.R.L.

Latest Health Care Equipment & Supplies and Integra LifeSciences Holdings Corporation, Stevanato Group S.p.A. Stock News

As of September 4, 2026, Integra LifeSciences Holdings Corporation had a $1.3 billion market capitalization, compared to the Health Care Equipment & Supplies median of $423.0 million. Integra LifeSciences Holdings Corporation’s stock is up 34.6% in 2026, down 1% in the previous five trading days and up 6.84% in the past year.

Currently, Integra LifeSciences Holdings Corporation does not have a price-earnings ratio. Integra LifeSciences Holdings Corporation’s trailing 12-month revenue is $1.6 billion with a -0.4% net profit margin. Year-over-year quarterly sales growth most recently was 0.8%. Analysts expect adjusted earnings to reach $2.457 per share for the current fiscal year. Integra LifeSciences Holdings Corporation does not currently pay a dividend.

As of September 4, 2026, Stevanato Group S.p.A. had a $5.6 billion market cap, putting it in the 69th percentile of all stocks. Stevanato Group S.p.A.’s stock is up 1.9% in 2026, down 2.5% in the previous five trading days and down 10.98% in the past year.

Currently, Stevanato Group S.p.A.’s price-earnings ratio is 36.6. Stevanato Group S.p.A.’s trailing 12-month revenue is $1.4 billion with a 11.0% net profit margin. Year-over-year quarterly sales growth most recently was 4.9%. Analysts expect adjusted earnings to reach $0.704 per share for the current fiscal year. Stevanato Group S.p.A. currently has a 0.3% dividend yield.

How We Compare Integra LifeSciences Holdings Corporation and Stevanato Group S.p.A. Stock Grades

Stock evaluation requires access to huge amounts of data and the knowledge and time to sift through it all, make sense of financial ratios, read income statements and analyze recent stock movements. AAII created A+ Investor, a robust data suite that condenses data research in an actionable and customizable way suitable for investors of all knowledge levels, to help investors streamline and work through such data.

AAII’s proprietary stock grades come with A+ Investor. These offer intuitive A‐F grades for each of five key investing factors: value, growth, momentum, earnings estimate revisions and quality. Here, we’ll take a closer look at Integra LifeSciences Holdings Corporation and Stevanato Group S.p.A.’s stock grades to see how they measure up against one another.

Learn more about A+ Investor here!

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

Integra LifeSciences Holdings Corporation and Stevanato Group S.p.A. Growth Grades

Company	Ticker	Growth
Integra LifeSciences Holdings Corporation	IART	B
Stevanato Group S.p.A.	STVN	A

The foundation of growth investing is seeking out stocks of companies exhibiting strong, consistent and prolonged growth that is expected to continue into the future.

In order to compute the growth score and assign it a letter grade, the percentile ranks for each of three components‐consistency of annual sales growth, five-year sales growth rankings adjusted for extreme levels, and consistency of positive annual cash from operations‐must be determined. These three rank figures are added together, and the sum is ranked against the entire stock universe to arrive at a company’s Growth Score to create an equal distribution of grades.

The companies in the bottom 20% of the stock universe receive Growth Grades of F, considered to be very weak, while those in the top 20% receive A grades, which are considered very strong.

Integra LifeSciences Holdings Corporation has a Growth Score of 73, which is Strong. Stevanato Group S.p.A. has a Growth Score of 83, which is Very Strong.

The Growth Grade Winner: Stevanato Group S.p.A.

As you can clearly see from the Growth Grade breakdown above, Stevanato Group S.p.A. has a more attractive growth grade than Integra LifeSciences Holdings Corporation. For investors who focus solely on how a company is growing relative to other companies in the same industry, Stevanato Group S.p.A. could be a good stock to add to their portfolio. However, it’s important for investors to analyze multiple factors based on a wide range of metrics before deciding whether to buy.

Integra LifeSciences Holdings Corporation and Stevanato Group S.p.A.’s Momentum Grades

Company	Ticker	Momentum
Integra LifeSciences Holdings Corporation	IART	C
Stevanato Group S.p.A.	STVN	D

Momentum grades help to uncover stocks experiencing anomalously high rates of return; research finds that stocks with high relative levels of momentum tend to outperform, whereas those with low levels of momentum tend to continue underperforming. Momentum is based on the price change of a stock over a specified period relative to all other stocks.

Typically, AAII looks at the weighted relative strength over the trailing four quarters. The weighted four-quarter relative strength rank is the relative price change for each of the past four quarters. The most recent quarterly price change is given a weight of 40% and each of the three previous quarters are given a weighting of 20%.

Integra LifeSciences Holdings Corporation has a Momentum Score of 56, which is Average. Stevanato Group S.p.A. has a Momentum Score of 40, which is Weak.

The Momentum Stock Winner: No Clear Winner

Neither Integra LifeSciences Holdings Corporation or Stevanato Group S.p.A. has a strong enough Momentum Grade to be considered a “winner.” Investors considering these companies should do additional due diligence and research to see if either could be a good addition to their portfolios. It’s important to look at a wide range of financial metrics in order to determine if Integra LifeSciences Holdings Corporation or Stevanato Group S.p.A. is the better investment when it comes to momentum.

Integra LifeSciences Holdings Corporation and Stevanato Group S.p.A.’s Estimate Revisions Grades

Company	Ticker	Earnings Estimate
Integra LifeSciences Holdings Corporation	IART	B
Stevanato Group S.p.A.	STVN	C

Earnings estimate revisions scores consider the magnitude of a company’s earnings surprise in its last two reported fiscal quarters. Often, positive surprises beget further positive surprises‐or at least continued sales growth (the exact opposite is generally true, too).

Estimate revisions offer an indication of what analysts are thinking about the short-term prospects of a firm. Estimate revisions are based on the statistical significance of a firm’s last two quarterly earnings surprises and the percentage change in its consensus estimate for the current fiscal year over the past month and past three months.

Integra LifeSciences Holdings Corporation has a Earnings Estimate Score of 66, which is Positive. Stevanato Group S.p.A. has a Earnings Estimate Score of 53, which is Neutral.

The Earnings Estimate Revisions Grade Winner: Integra LifeSciences Holdings Corporation

As you can clearly see from the Earnings Estimate Revisions Grade breakdown above, Integra LifeSciences Holdings Corporation has a better Earnings Estimate Revisions Grade than Stevanato Group S.p.A.. For those who are specifically looking for companies with better short-term prospects when compared to other companies in the same industry, Integra LifeSciences Holdings Corporation could be a good stock to invest in. However, it’s important to analyze multiple factors based on a wide range of metrics before deciding whether to buy.

Other Integra LifeSciences Holdings Corporation and Stevanato Group S.p.A. Grades

In addition to Estimate Revisions, Momentum and Growth, A+ Investor also provides grades for Value and Quality.

Successful stock investing involves buying low and selling high, so stock valuation is an important consideration for stock selection. Buying stocks that are going to go up typically means buying stocks that are undervalued in the first place, although momentum investors may argue that point.

AAII’s A+ Investor Quality Grade comes from the ranking of key metrics. Specifically, the quality grade is the percentile rank of the composite of return on assets (ROA), return on invested capital (ROIC), gross profit relative to assets, buyback yield, change in total liabilities to assets, accruals, Z double prime bankruptcy risk (Z) score and F-Score.

These 2 key factors, when combined with the above, provide a holistic view into a particular stock. Further, by joining A+ Investor you can see whether Integra LifeSciences Holdings Corporation and Stevanato Group S.p.A. pass any of our 60+ stock screens that have outperformed the market since their creation.

So, Which Is the Better Investment, Integra LifeSciences Holdings Corporation or Stevanato Group S.p.A. Stock?

Overall, Integra LifeSciences Holdings Corporation stock has a Growth Score of 73, Momentum Score of 56 and Estimate Revisions Score of 66.

Stevanato Group S.p.A. stock has a Growth Score of 83, Momentum Score of 40 and Estimate Revisions Score of 53.

Comparing Integra LifeSciences Holdings Corporation and Stevanato Group S.p.A.’s grades, scores and metrics can act as a solid basis to determine whether they may be a good investment or not. You’ll also want to look at your portfolio’s asset allocation as well as your risk tolerance and financial goals to see if either of these stocks would make a good fit for you. AAII can help you figure out which investments align with your individual needs and preferences.

Investors are encouraged to do their own due diligence and research. In this way, individuals can effectively become managers of their own assets‐without having to rely on others for financial independence. You can count on AAII for timeless articles on financial planning and stock-picking, unbiased research and actionable analysis.

A+ Investor adds to our qualitative teaching with a powerful data suite to help you whittle down investment choices to find stocks, exchange-traded funds (ETFs) or mutual funds that meet your needs.

AAII Disclaimer

We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown, because past, hypothetical or simulated performance is not necessarily indicative of future results. Before making an investment decision, you should consider your circumstances and whether the information on our content is applicable to your situation. This information was prepared in good faith, and we accept no liability for any errors or omissions. The full disclaimer can be read here.